Paydirt
KS
Insider

Karimah Es Sabar

Director

Karimah Es Sabar (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Capricor Therapeutics, Inc. (CAPR). The largest single filing was $3.5M of CAPR (115,000 sh across 2 lots, as filed), executed Mar 31.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.8M
shares × price, as filed
Last traded
Apr 2
Filed Apr 3

Median ADV $33.1M across their filed names

Open performance
Volume by month
$3.8M$1.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $3.8M
Buys $0 Sells $3.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
CAPR Capricor Therapeutics, Inc. CAPR · 0 buys · 2 sells 2 filings
Recent filings
CAPRSALE Capricor Therapeutics, Inc. View filing → $241K
7,529 sh × $32.00
Exec Apr 2
Filed Apr 3 · 5:30 PM ET
CAPRSALE Capricor Therapeutics, Inc. View filing → $3.5M
115,000 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET